Self-limiting reactive disease mimicking polymyalgia rheumatica following Moderna COVID-19 vaccine.

Nielsen, A W; Hansen, I T; Gormsen, L C; Hauge, E-M; Keller, K K

Nielsen, A W; Hansen, I T; Gormsen, L C; Hauge, E-M; Keller, K K.

Nielsen AW; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Hansen IT; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Gormsen LC; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Hauge EM; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Keller KK; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Scand J Rheumatol ; 51(5): 411-413, 2022 09.

Article in English | MEDLINE | ID: covidwho-1878601

Subject(s)

COVID-19; Giant Cell Arteritis; Polymyalgia Rheumatica; 2019-nCoV Vaccine mRNA-1273; COVID-19/prevention & control; Diagnosis, Differential; Giant Cell Arteritis/diagnosis; Humans; Polymyalgia Rheumatica/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Polymyalgia Rheumatica / Giant Cell Arteritis / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Scand J Rheumatol Year: 2022 Document Type: Article Affiliation country: 03009742.2022.2070959

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google